Product Information
PREGABALIN 150 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0542 per EA under NDC 64980041410. Its NADAC has been published 362 times since Oct 30, 2019.
FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980041410
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA210432FDA Approved
7/19/2019
TE Code
AB
On Market Since
7/19/2019
Price Statistics
The NADAC for PREGABALIN 150 MG CAPSULE has been published 362 times since Oct 30, 2019, and over the history we have for it it has declined 68.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0542 per EA |
|---|---|
| All-time high | $0.1773 (Jun 10, 2020) |
| All-time low | $0.0489 (Jul 22, 2026) |
| 52-week high | $0.0582 |
| 52-week low | $0.0489 |
| Median price | $0.0764 |
| Average price | $0.0898 |
| Largest weekly change | +32.6% (Aug 21, 2024) |
| Weeks tracked | 362 |
| Tracking since | Oct 30, 2019 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PREGABALIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREGABALIN 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 150 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0542 per EA (NDC 64980041410), effective Sep 30, 2026.
How has the price of PREGABALIN 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 150 MG CAPSULE has declined 68.2%. It has been tracked across 362 weekly CMS publications since Oct 30, 2019.
What are the highest and lowest recorded NADAC prices for PREGABALIN 150 MG CAPSULE?
Since Oct 30, 2019, the NADAC for PREGABALIN 150 MG CAPSULE has ranged from a low of $0.0489 (Jul 22, 2026) to a high of $0.1773 (Jun 10, 2020), with a median of $0.0764 per EA.
Are there cheaper alternatives to PREGABALIN 150 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PREGABALIN 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PREGABALIN 150 MG CAPSULE?
PREGABALIN 150 MG CAPSULE (NDC 64980041410) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.